loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 208692 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Exelixis

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 EXELIXIS INC (3)

    filter

    01 TABLET;ORAL (3)

    filter

    01 RX (3)

    filter

    01 CABOMETYX (3)

    filter

    01 Yes (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      CABOZANTINIB S-MALATE

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET; ORAL
      EQ 20MG BASE
      2016-04-25
      208692
      CABOMETYX
      RX
      Yes
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        CABOZANTINIB S-MALATE

        PDF Supplier PDF
        URL Supplier Web Content
        TABLET; ORAL
        EQ 40MG BASE
        2016-04-25
        208692
        CABOMETYX
        RX
        Yes
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag U.S.A
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          CABOZANTINIB S-MALATE

          PDF Supplier PDF
          URL Supplier Web Content
          TABLET; ORAL
          EQ 60MG BASE
          2016-04-25
          208692
          CABOMETYX
          RX
          Yes
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          Looking for FDA Orange Book APPLICATION 208692

          Looking for FDA Orange Book APPLICATION 208692 3

          19

          Exelixis, based in U.S.A, is a pharmaceutical company.

          One of their notable products is CABOZANTINIB S-MALATE, with a corresponding application number 208692.

          Regulatory Information RX

          With a dosage strength EQ 20MG BASE

          Dosage Form Route TABLET; ORAL

          Reference Listed Drug Yes

          Approved since 2016-04-25

          18

          Exelixis, based in U.S.A, is a pharmaceutical company.

          One of their notable products is CABOZANTINIB S-MALATE, with a corresponding application number 208692.

          Regulatory Information RX

          With a dosage strength EQ 40MG BASE

          Dosage Form Route TABLET; ORAL

          Reference Listed Drug Yes

          Approved since 2016-04-25

          17

          Exelixis, based in U.S.A, is a pharmaceutical company.

          One of their notable products is CABOZANTINIB S-MALATE, with a corresponding application number 208692.

          Regulatory Information RX

          With a dosage strength EQ 60MG BASE

          Dosage Form Route TABLET; ORAL

          Reference Listed Drug Yes

          Approved since 2016-04-25

          Post Enquiry
          POST ENQUIRY